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Background: Variants in the emerin gene (EMD) were implicated in X-linked recessive Emery-Dreifuss muscular
dystrophy (EDMD), characterized by early-onset contractures of tendons, progressive muscular weakness and
cardiomyopathy. To date, 223 mutations have been reported in EMD gene and the majority of them caused
a predominant skeletal muscular phenotype. In this study, we identified a novel deletion mutation in EMD exon 1,
which results in almost a complete loss of emerin protein in a large Chinese family. However, the patients suffered
severe dilated cardiomyopathy (DCM) but very mild skeletal muscle disorder.
Case presentation: Whole exome sequencing (WES) and linkage analysis were performed to identify the underlying
mutation in a Chinese DCM family spanning five generations. A missense variation in the GPR50 gene was found
co-segregated with the disease phenotype, whereas no functional alteration was detected in the variant
GPR50 protein. When analyzing the failure sequences in the exome sequencing data, a novel deletion mutation
(c.26_39delATACCGAGCTGACC) in EMD exon 1, was identified in this family. Different from the typical clinical features
caused by most reported EMD mutations, patients in our study presented very mild skeletal muscle degeneration that
had not been diagnosed until the mutation was found.
Conclusion: We described a family with rare clinical presentations caused by a novel EMD deletion mutation. Our
findings broaden the heterogeneous spectrum of phenotypes attributed to EMD mutations and provide new insight to
explain the genotype-phenotype correlations between EMD mutations and EDMD symptoms.
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The EMD gene, consisting of 6 exons and encoding a
nuclear envelope protein emerin (254 amino acids), was
involved in X-linked Emery-Dreifuss muscular dystrophy
(EDMD) [1]. Among the 223 reported EMD mutations in
the Leiden Open Variation Database (LOVD), the over-
whelming majority of mutations have been identified
in EDMD patients who presented childhood-onset con-
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unless otherwise stated.cervical muscles, slowly progressive muscle weakness
with humeroperoneal distribution in adolescence and
cardiomyopathy with conduction block in early adult-
hood [1,2].
Dilated cardiomyopathy (DCM) is a common cause of
advanced heart failure and the primary indication for
heart transplantation [3]. Currently over 40 individual
genes that encode for sarcomeric, cytoskeletal, nuclear
membrane, dystrophin-associated glycoprotein complex
and desmosomal proteins have been implicated in inher-
ited DCM [3,4]. One of the most common nonsyndromic
DCM-causing genes is LMNA, which encodes the nuclear
lamina proteins lamin A and C; mutations in this gene
also cause autosomal dominant and recessive EDMDLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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are very similar, the EMD gene is not listed in the routine
screening of DCM because of lacking sufficient body evi-
dences [4].
In this study, we conducted WES combined with linkage
analysis to identify the underlying mutation in a large
Chinese DCM family. A missense variation in the GPR50
gene was found co-segregated with the disease phenotype,
whereas no functional alteration was detected in the vari-
ant GPR50 protein. When analyzing the failure sequences
in the WES data, a novel deletion mutation (c.26_39delA
TACCGAGCTGACC) in EMD exon1, which results in
almost a complete loss of emerin protein, was identified
in this family. Different from the typical clinical features
caused by most reported EMD mutations, the patients in
our study presented severe DCM but very mild skeletal
atrophy.Figure 1 Haplotype analysis of family pedigree and ultrasonic card
the pedigree are identified by their Roman numerals below the symbo
symbols = unaffected; filled symbols = affected; symbols with a diagona
the probands; Haplotype analysis is shown for chromosome X using 11
the disease allele. The bars with black and white haplotypes indicate t
6.2 Mb of genomic DNA, 20.9 cM in size between DXS8091 and DXS1073 on
chamber enlargement. LA = left atrium; LV = left ventricle; RA = right atrium; RCase presentation
Materials and methods
Subjects
A pedigree from Jilin Province, China, consists of 73 fam-
ily members (40 males and 33 females) in five generations
(Figure 1A). Familial DCM was diagnosed according to
WHO1995 diagnostic criteria (left ventricle end diastolic
diameter > 2.7 cm/m2; fractional shortening < 25%). The
study was approved by the expert committee of hospital
of the Jilin University in China (equivalent to an institu-
tional review board).
Linkage analysis
Peripheral blood of 39 family members was obtained. Gen-
omic DNA was extracted from the peripheral blood lym-
phocytes, using the standard phenol–chloroform method.
A total of 22 subjects were included in the linkage studyiogram (UCG) study of proband A. (A) All sampled subjects in
l. Arabic numerals denote each individual in a generation. Open
l line = deceased subjects; squares = male; circles = female; arrows =
markers. The black bar indicates the haplotype assumed to carry
he existence of recombination event. The minimal in-linkage interval is
chromosome Xq28. (B) Ultrasonic cardiogram study of proband A shows
V = right ventricle.
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formed using 18 microsatellite markers (Panel 28, Version
2.5, ABI PRISM Linkage Mapping Set) in X chromosome.
Five additional markers (DXS998, DXS1193, DXS8069,
DXS8011, DXS8103) were chosen to refine mapping the
gene locus. Two-point LOD scores were calculated by the
program MLINK, and multipoint LOD scores with use of
Linkmap. The disease was considered to be X-linked with
a frequency of 0.0001 and 95% penetrance.
Exome sequencing
Five micrograms of DNA from each of two affected male
individuals was applied for the construction of exome li-
brary using the Agilent SureSelect exome capture system
and was sequenced on the Illumina Solexa GAIIx plat-
form following the manufacturer’s instructions (Illumina,
San Diego, CA). Raw image files were processed by the
Illumina pipeline (version 1.3.4) for base calling and gen-
erating the reads set.
Reads were aligned to the human reference genome
(University of California Santa Cruz, UCSC hg19) using
SOAPaligner. Single nucleotide polymorphisms (SNPs)
and indels (insertions and deletions) identification was
performed by samtools and/or Genome Analysis Toolkit
(GATK) and such SNPs with read depth > 4 and quality >
20 were reserved for subsequent analysis. SNPs and indels
were annotated using SeattleSeq annotation. On the
basis of SNP database (dbSNP) and 1000 genomes an-
notation and the supplied PolyPhen prediction, any non-
synonymous variants not assigned a ‘benign’ prediction
were considered to be damaging.
Analysis of candidate genes
DNA sequences were obtained from GenBank. Primers
were designed with primer-3 software. Protein-encoding
exons of candidate genes were amplified from genomic
DNA. PCR products were purified with use of kits (golden
polymerase, ABI, California) and sequenced with a dye-




All the individuals in the family were interviewed, and re-
ported symptoms of cardiomyopathy disease such as chest
pain, shortness of breath and fatigue; 8 males and 4 fe-
males were identified with clinical symptoms (Figure 1A).
Sudden cardiac death was reported in five of eight male
patients at the age of 25, 30, 33, 33 and 42 years old. The
female patients presented milder heart failure and less
life-threatening symptoms than the males. The proband
A (III: 19) was initially diagnosed as sick sinus syndrome
with chest tightness and early onset fatigue, especially
after heavy activity, and his electrocardiogram (ECG)showed sinus bradycardia (sinus node dysfunction), with a
minimum heart rate of 36 times/min at the age of 17 years.
The symptoms progressively became more severe when
the patient was 34 years old. The pacemaker implantation
failed and the ultrasonic cardiogram (UCG) showed
chamber enlargement (left ventricular end-diastolic diam-
eter of 56.8 mm, the right atrium 65 × 83 mm, right room
26.4 mm, left atrial 54.2 mm) (Figure 1B), with a thinning
of the chamber wall. The subject was hospitalized at the
age of 41 years; the 24-h Holter detected paroxysmal ven-
tricular tachycardia and sudden death occurred 1 month
after discharge. A similar cardiac disorder has been identi-
fied in other patients in the family, but not among un-
affected members.Candidate genes analysis and Linkage study
Genetic and clinical evaluation of the pedigree provides
the evidence of an X-linked recessive inheritance. DMD
and TAZ are the two reported genes associated with
X-linked nonsyndromic DCM [3]. No deletion or in-
sertion was observed in the DMD gene of proband A
using the method of multiplex ligation-dependent probe
amplification (MLPA) and Sanger sequencing did not
detect any mutation in the exons and exon-intron junc-
tions of both strands in the TAZ gene. Linkage analyses in
the family identified a locus associated with DCM on
chromosome X, band Xq28 (maximal lod score 1.55 at
DXS1073). Five additional markers were analyzed to nar-
row the positive candidate region, defined a common
haplotype in all the affected subjects, yielding a maximum
2-point LOD score of 2.43 with a marker located at
DXS1193 (Figure 1A).Whole exome sequencing
Whole exomes of two affected male individuals in the
family (sample III: 11 and IV: 6) were sequenced, gener-
ating an average of 4.5 billion bases of sequence and a
mean coverage of 65× for each affected individual. An
average of 97% of the targeted bases was sufficiently cov-
ered to pass our thresholds for variant calling. Variants
of 73 hereditary cardiomyopathies related genes were
screened [5], the filtering conditions are as following: (1)
same variants in both WES data; (2) missense, nonsense,
insertion and deletion variants; (3) SNPs with minor
allele frequency not more than 0.005 according to the
SNP database of National Center for Biotechnology In-
formation (NCBI). 7 variants passed the filtering condi-
tions and none of them co-segregated with the disease
phenotype. Then 140 genes in the linked locus (Xq28)
were also screened according to the above conditions. 9
variants passed the conditions and only the GPR50
c.113C > T variant was found co-segregation with the
disease phenotype.
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GPR50 is a member of G-protein coupled receptor 1
family and known as a melatonin-related orphan recep-
tor. The physiological functions of this protein are still
largely unknown [6]. The variant c.113C > T (rs189225995)
in GPR50 was tested in 1500 controls (314 males and 593
females, normal unaffected individuals of matched geo-
graphical ancestry) and found in 2 females. The substitu-
tion of polar Thr to nonpolar Ile caused by the variant in
the first transmembrane domain of GPR50 did not alter
the three-dimensional structure when predicted using the
Phyre2 server and seven temples (SCOP codes: c2ksaA
[human Substance-P receptor], c3rzeA [Histamine H1 re-
ceptor], c2rh1A [β2 adrenergic receptor], c3emlA [Human
Adenosine A2A receptor], c4djhA [human j-type opioid
receptor], c3uonA [human M2 muscarinic acetylcholine
receptor], c3pdsA [human b2-adrenergic receptor]). Fur-
ther, both the variant and wildtype GPR50 protein could
locate on the plasma membrane when transfected into
HEK293 cells (Figure 2B). GPR50 could alter melatonin-
induced MT1 signaling, which couples the Gi protein inhi-
biting phosopholipase C activation and decreases cAMP
levels through heterodimerization [6]; however, no appar-
ent variation in cAMP signalling was detected when the
variant and wildtype GPR50 protein were co-transfectedFigure 2 Identification and functional study of the GPR50 variant. (A)
(WT) subject and proband B confirms the presence of the T38I variation. Th
wild-type and variant GPR50 protein both located on the membrane of HE
transfected into HEK293 cells. The red plasma membranes were labeled by
(C) The variant GPR50 protein did not alter the effect on melatonin-induced
into MT1 stable transfection HEK293 cells, no difference of cAMP levels was d
(ns, P > 0.05).with MT1 in HEK293 cells (Figure 2C). These experiments
suggest that the variant is unlikely to be sufficient to cause
DCM in the pedigree.
Mutation detection and proband reexamination
Further analyzing the WES data revealed that twenty
exons of 10 genes on the linked locus were demonstrated
sequencing failure due to a high GC-content. Sanger se-
quencing was performed to screen these exons. A 14-bp
deletion mutation (c.26_39delATACCGAGCTGACC) in
the EMD exon 1, with no record in the LOVD, causing a
frameshift and a premature stop codon at position 81, and
generating a truncated 26-amino acid polypeptide, was
identified in all the patients and absent in unaffected fam-
ily members (Figure 3A). Considering that most mutations
in the EMD caused severe skeletal muscle disorder, the
proband B (III: 25) who had suffered from sinus bradycar-
dia with a minimum heart rate of 42 times/min was reexa-
mined. A mild atrophy was observed in the patient’s bicep
and tricep muscles on the arms (Figure 3B), and a gentle
contraction was detected in his spinal column. However,
no contraction had been detected in his elbows and
Achilles tendons, and weakness or atrophy was not ob-
served in his calf muscles, which were surprisingly as
strong as unaffected family members (Figure 3B).Sanger sequence of codons 37-39 in exon 1 of GPR50 in a wild-type
e variant nucleotide residue is indicated by a red rectangular. (B) The
K293 cells. GFP-tagged GPR50 wild-type and variant plasmids were
Concanavalin A (Con A) and the nuclei were stained blue with DAPI.
MT1 signaling. GPR50 wild-type and variant plasmids were transfected
eteced when treated with forskolin and melatonin, 48 h after trnasfection
Figure 3 The proband B carrying a novel deletion mutation in EMD presented mild skeletal disorder. (A) Sanger sequence of codons
8-15 in exon 1 of EMD in a wild-type subject and proband B confirms the 14-bp deletion mutation (c.26_39delATACCGAGCTGACC). (B) A mild
atrophy was observed in the proband B’s bicep and tricep muscles on the arm, no contraction had been detected in his elbows and Achilles
tendons, and his calf muscles were surprisingly strong. (C) Hematoxylin-eosin staining of deltoid biopsy from proband B showed clear cross
striation and normal myofilament fibers. Internally located nuclei and fiber splitting were found. Endomysial fibrosis and sarcoplasmic condensation
were occasionally noted.
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at 442 U/L (normal = 24-190 U/L). The electromyography
(EMG) evaluation identified myogenic damage. The ampli-
tude and duration of motor unit potentials in right biceps
brachii and right deltoid were reduced, but no obvious
abnormality was found in both sides of gastrocnemius
muscle. The conduction velocity of motor and sensory
fibers was normal. The biopsy of deltoid showed clear
cross striation and normal myofilament fibers. Internally
located nuclei and fiber splitting were found. Endomysial
fibrosis and sarcoplasmic condensation were occasionally
noted (Figure 3C).
Discussion
In this study, we performed WES and linkage analysis to
identify a novel mutation in the EMD gene in a large
Chinese DCM family. The WES ruled out the mutationsin the exons of all reported nonsyndromic DCM-causing
genes and found a single-nucleotide variant in GPR50
gene which was completely co-segregated with the disease
phenotype. But the following functional studies did not re-
veal any functional change between the wild-type and
variant GPR50 protein. These results pushed us to screen
the sequencing failure exons in the WES data and eventu-
ally the disease-causing mutation in EMD was found. This
process highlighted the indispensability of functional study
in identifying new disease-causing genes and the import-
ance of analyzing the sequencing failure data of WES.
Most reported mutations in the EMD gene caused ap-
parent skeletal muscle disorders with cardiomyopathy in
the form of EDMD [1,2]. A novel deletion mutation in
EMD exon 1 which results in almost a complete loss of
emerin protein was identified in the pedigree. However,
different from the typical EDMD clinical features caused
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did not present apparent skeletal muscle atrophy and con-
tractures. To date, only three EMD mutations (an in-frame
3-bp deletion in exon 2, a 5-bp deletion and a nonsense
mutation in exon 6) were reported in patients with
predominant cardiac diseases and mild skeletal muscle
disorder [7-9]. These cases together with our findings
pointed out that environmental or genetic modifications,
such as functional overlapping proteins complement, may
contribute to the observed clinical variability caused by
EMD mutations.
Emerin is a member of the LEM-domain protein family,
which presents a group of inner nuclear membrane and
intranuclear proteins such as lamina-associated polypep-
tide 2 (LAP2) and MAN antigen 1 (MAN1) [1]. Key com-
ponents of the Rb pathway, which plays a crucial role in
E2F-mediated cell cycle regulation and MyoD-mediated
induction of myogenesis, were specifically altered in
human muscle biopsies of EDMD patients [10]. Emerin-
knockout mice also revealed that Rb1 and MyoD expres-
sion levels and pathways during muscle regeneration were
disrupted even though no overt abnormality was observed
[11]. Consistently, the protein levels of MyoD decreased
in the complete and muscle-specific knockout mice of
LAP2α, which is a mammal-specific non-membrane-
associated isoform of the LAP2 gene [12]. A mutation in
the C-terminal tail of LAP2α has also been linked to
DCM [13]. These findings provided evidences that emerin
and LAP2α may have some overlapping functions in the
process of muscle regeneration and differentiation. Con-
sidering common cardiac disorder but diverse skeletal
muscle involvement observed among the patients carrying
EMD mutations, the functional complement from LAP2α
and environmental effect may partly contribute to skeletal
muscle regeneration.
Conclusion
We applied WES and linkage analysis to identify a novel
deletion mutation in EMD exon 1 (c.26_39delATACC
GAGCTGACC) in a Chinese family spanning five gener-
ations. Different from the typical clinical features caused
by the majority of reported EMD mutations, the patients
in our study present severe DCM but very mild skeletal
muscle disorder. Our study suggests the EMD gene,
which was not listed in the routine screening of DCM,
should be considered in patients with DCM of unknown
etiology and further functional studies of emerin in skel-
etal and cardiac muscle cells are needed to illustrate the
phenotypic heterogeneity caused by EMD mutations.
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